Shared on04 Sep 25
The consensus analyst price target for CareTrust REIT was maintained at $36.89, as analysts cite the successful equity offering and strengthened balance sheet as supporting a robust investment pipeline and near-term growth. Analyst Commentary Upsized follow-on equity offering generating $736M in gross proceeds, providing significant funding.
Shared on20 Aug 25Fair value Increased 10%
CareTrust REIT’s consensus price target was raised to $35.33 as analysts anticipate enhanced growth and financial flexibility following a successful capital raise, robust investment pipeline, and strengthened balance sheet. Analyst Commentary Successful completion of a 20M share upsized issuance, providing gross proceeds up to $736M, which increases liquidity and funds investment opportunities.
Shared on30 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 0.35%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget has increased revenue growth from 19.5% to 29.0% and decreased profit margin from 62.4% to 49.6%.
Shared on02 Apr 25Fair value Increased 9.00%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 0.70%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 1.13%
AnalystConsensusTarget has increased revenue growth from 12.9% to 19.5%, decreased profit margin from 96.6% to 62.4% and increased future PE multiple from 21.3x to 28.1x.
Shared on11 Mar 25Fair value Decreased 4.07%
AnalystConsensusTarget has decreased revenue growth from 16.0% to 12.9% and decreased future PE multiple from 28.1x to 21.3x.